LT3347002T - Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje - Google Patents
Alzheimerio ligos gydymas tam tikroje pacientų populiacijojeInfo
- Publication number
- LT3347002T LT3347002T LTEPPCT/US2016/051091T LT16051091T LT3347002T LT 3347002 T LT3347002 T LT 3347002T LT 16051091 T LT16051091 T LT 16051091T LT 3347002 T LT3347002 T LT 3347002T
- Authority
- LT
- Lithuania
- Prior art keywords
- alzheimer
- disease
- treatment
- particular patient
- patient population
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562216404P | 2015-09-10 | 2015-09-10 | |
| US201662290287P | 2016-02-02 | 2016-02-02 | |
| US201662302027P | 2016-03-01 | 2016-03-01 | |
| US201662365809P | 2016-07-22 | 2016-07-22 | |
| PCT/US2016/051091 WO2017044840A1 (en) | 2015-09-10 | 2016-09-09 | Methods of treating neurodegenerative disorders in a particular patient population |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3347002T true LT3347002T (lt) | 2023-09-11 |
Family
ID=58240195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2016/051091T LT3347002T (lt) | 2015-09-10 | 2016-09-09 | Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11191742B2 (lt) |
| EP (2) | EP4275750A3 (lt) |
| JP (3) | JP6789579B2 (lt) |
| KR (2) | KR102547164B1 (lt) |
| CN (3) | CN116712422A (lt) |
| AU (1) | AU2016319107B2 (lt) |
| CA (1) | CA2997376C (lt) |
| DK (1) | DK3347002T3 (lt) |
| ES (1) | ES2952727T3 (lt) |
| FI (1) | FI3347002T3 (lt) |
| HK (1) | HK1257874A1 (lt) |
| HR (1) | HRP20230809T1 (lt) |
| HU (1) | HUE062511T2 (lt) |
| LT (1) | LT3347002T (lt) |
| MD (1) | MD3347002T2 (lt) |
| MX (2) | MX2018003023A (lt) |
| PL (1) | PL3347002T3 (lt) |
| PT (1) | PT3347002T (lt) |
| RS (1) | RS64481B1 (lt) |
| SI (1) | SI3347002T1 (lt) |
| WO (1) | WO2017044840A1 (lt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015230972B2 (en) | 2014-03-21 | 2021-05-27 | Alzheon, Inc. | Methods for treating neurological disorders |
| LT3347002T (lt) * | 2015-09-10 | 2023-09-11 | Alzheon, Inc. | Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje |
| CN108623501B (zh) | 2017-03-21 | 2022-04-19 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸衍生物及其用途 |
| CN110003058B (zh) * | 2018-01-04 | 2022-01-25 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途 |
| SG11202100767XA (en) * | 2018-08-01 | 2021-02-25 | Alzheon Inc | Methods for treating neurodegenerative disorders |
| US20220087967A1 (en) * | 2018-08-01 | 2022-03-24 | Alzheon, Inc. | Sulfopropanoic acid derivatives for treating neurodegenerative disorders |
| CN111170901A (zh) * | 2018-11-13 | 2020-05-19 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途 |
| WO2020257159A1 (en) | 2019-06-17 | 2020-12-24 | Alzheon, Inc. | Methods for treating neurodegenerative disorders |
| AU2022405026A1 (en) * | 2021-12-09 | 2024-06-20 | Alzheon, Inc. | Alz-801 for use in treating alzheimer's disease |
| WO2023150381A1 (en) * | 2022-02-07 | 2023-08-10 | Alzheon, Inc. | Alz-801 for use in treating a covid-19 associated neurological symptom |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| JP3265577B2 (ja) | 1992-10-13 | 2002-03-11 | デューク・ユニバーシティ | アポリポ蛋白ｅの４型イソ型の測定法 |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| US20060079578A1 (en) | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| SG145784A1 (en) | 2003-08-11 | 2008-09-29 | California Inst Of Techn | Microfluidic large scale integration |
| CA2611586A1 (en) | 2005-04-12 | 2007-06-21 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| WO2009019534A2 (en) | 2006-10-12 | 2009-02-12 | Bellus Health (International) Limited | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| US20100183513A1 (en) | 2006-11-24 | 2010-07-22 | Wolfgang Froestl | N-(methyl) -1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| US20120009125A1 (en) | 2010-07-06 | 2012-01-12 | Lombard Jay L | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| ES2705027T3 (es) | 2010-08-19 | 2019-03-21 | Buck Institute For Age Res | Métodos de tratamiento del deterioro cognitivo leve (DCL) y trastornos relacionados |
| ES2740127T3 (es) * | 2013-05-06 | 2020-02-05 | Baxalta Inc | Tratamiento de subpoblaciones con enfermedad de Alzheimer con inmunoglobulina G combinada |
| KR20160111039A (ko) | 2014-02-08 | 2016-09-23 | 제넨테크, 인크. | 알츠하이머 질환을 치료하는 방법 |
| AU2015230972B2 (en) | 2014-03-21 | 2021-05-27 | Alzheon, Inc. | Methods for treating neurological disorders |
| LT3347002T (lt) * | 2015-09-10 | 2023-09-11 | Alzheon, Inc. | Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje |
-
2016
- 2016-09-09 LT LTEPPCT/US2016/051091T patent/LT3347002T/lt unknown
- 2016-09-09 RS RS20230603A patent/RS64481B1/sr unknown
- 2016-09-09 US US15/758,405 patent/US11191742B2/en active Active
- 2016-09-09 JP JP2018512564A patent/JP6789579B2/ja active Active
- 2016-09-09 WO PCT/US2016/051091 patent/WO2017044840A1/en active Application Filing
- 2016-09-09 AU AU2016319107A patent/AU2016319107B2/en active Active
- 2016-09-09 EP EP23176559.5A patent/EP4275750A3/en active Pending
- 2016-09-09 CN CN202310582365.9A patent/CN116712422A/zh active Pending
- 2016-09-09 KR KR1020227009418A patent/KR102547164B1/ko active IP Right Grant
- 2016-09-09 HU HUE16845181A patent/HUE062511T2/hu unknown
- 2016-09-09 FI FIEP16845181.3T patent/FI3347002T3/fi active
- 2016-09-09 CN CN202310582394.5A patent/CN116712423A/zh active Pending
- 2016-09-09 SI SI201631729T patent/SI3347002T1/sl unknown
- 2016-09-09 MD MDE20180700T patent/MD3347002T2/ro unknown
- 2016-09-09 PL PL16845181.3T patent/PL3347002T3/pl unknown
- 2016-09-09 KR KR1020187009381A patent/KR102412997B1/ko active IP Right Grant
- 2016-09-09 ES ES16845181T patent/ES2952727T3/es active Active
- 2016-09-09 HR HRP20230809TT patent/HRP20230809T1/hr unknown
- 2016-09-09 CA CA2997376A patent/CA2997376C/en active Active
- 2016-09-09 PT PT168451813T patent/PT3347002T/pt unknown
- 2016-09-09 DK DK16845181.3T patent/DK3347002T3/da active
- 2016-09-09 EP EP16845181.3A patent/EP3347002B1/en active Active
- 2016-09-09 CN CN201680052760.4A patent/CN108289870A/zh active Pending
- 2016-09-09 MX MX2018003023A patent/MX2018003023A/es unknown
-
2018
- 2018-03-09 MX MX2022003128A patent/MX2022003128A/es unknown
-
2019
- 2019-01-07 HK HK19100235.4A patent/HK1257874A1/zh unknown
-
2020
- 2020-09-28 JP JP2020161995A patent/JP7128536B2/ja active Active
-
2021
- 2021-09-17 US US17/477,886 patent/US20220096406A1/en not_active Abandoned
-
2022
- 2022-08-12 JP JP2022128786A patent/JP2022145949A/ja active Pending
-
2023
- 2023-09-06 US US18/462,238 patent/US20230414541A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE062511T2 (hu) | Alzheimer-kór kezelése egy adott betegpopulációban | |
| IL247085A0 (en) | Methods for treating Alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| PL3119911T3 (pl) | Związki do zastosowania w leczeniu choroby alzheimera u pacjentów apoe4+/+ | |
| EP3347486A4 (en) | REDUCTION OF ER-MAM-LOCALIZED APP-C99 AND METHOD FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| HK1243709A1 (zh) | 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物 | |
| EP3137097C0 (en) | TREATMENT AND PREVENTION OF ALZHEIMER | |
| SI3413870T1 (sl) | Igmezin za uporabo pri zdravljenju alzheimerjeve bolezni | |
| PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
| PL3137093T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| HK1257598A1 (zh) | 改善心臟病變的藥物及其用途 | |
| IL260009B (en) | Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | |
| GB201511453D0 (en) | Treatment of alzheimer's disease | |
| HK1245081A1 (zh) | 用於治療阿爾茨海默病的方法 | |
| AU2017902309A0 (en) | Treatment of alzheimer's disease | |
| AU2017902307A0 (en) | Treatment of alzheimer's disease | |
| GB201518052D0 (en) | Parkinson's disease treatment | |
| GB201504144D0 (en) | Treatment of Parkinson's disease |